The average scores of delayed hypersensitivity skin tests using seven different agents, i.e. PPD, Candida, SK-SD, Mumps, Varicella, PHA and DNCB, were examined in relationship to the following items in patients with head and neck malignancies.
1) Multivariate analysis was applied to the classification of six clinical stages mentioned as followed: patients with no evidence of the disease (NED) more than 6 months after treatment, patients with NED within 6 months, patients under treatment with active tumours, patients with far advanced tumours, patients in fatal stage and control. It revealed the fact that clinical stages are based to some extent upon the results from the routine clinical tests and from the delayed hypersensitivity skin test. The first one of two canonical axis examined have may be related to cellular immunization and the second to inflamation.
2) Routine laboratory tests were well correlated to the scores, as accounted for by variables denoting general debility, such as reduced blood count, weight loss, and poor physical activity, as well as impaired immunological indices such as reduced lymphocyte count and serum protein fractions.
3) TNM stages, as a whole, advanced as the scores decreased: the larger the primary tumour mass or the more evidence of metastases, the smaller were the average scores.
4) Transition of clinical stages usually paralleled the scores, except in some cases in which the correlation was paradoxica. The average amount of changes in the scores, however, did not reach the level of significance.
5) Examination of the scores for ability to predict clinical outcome, with the rate of nonrecurrence for the subsequent two years as an index, revealed the absence of significant difference between NED (more than 6 months) patients presenting normal skin reactions and those presenting deficient skin reactions, and the presence of a 10% difference between patients presenting on the treatment normal skin reactions and those presenting deficient skin reactions.
View full abstract